{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:35:40Z","timestamp":1793637340453,"version":"4.5.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.sapharm.2024.02.016","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:41:13Z","timestamp":1709397673000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A systematic review of synchronous telepharmacy service models for adult outpatients with cancer"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9223-0740","authenticated-orcid":false,"given":"Marissa","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Poke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Carrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Centaine L.","family":"Snoswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.sapharm.2024.02.016_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.sapharm.2017.10.011","article-title":"Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review","volume":"14","author":"Niznik","year":"2018","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2024.02.016_bib2","article-title":"Oncology pharmacists can reduce the Projected Shortfall in cancer patient visits: Projections for Years 2020 to 2025","volume":"8","author":"Knapp","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.sapharm.2024.02.016_bib3","article-title":"Telepharmacy: a systematic review of Field Application, benefits, limitations, and Applicability during the COVID-19 pandemic","author":"Dat","year":"2022","journal-title":"Telemed J e Health"},{"issue":"7","key":"10.1016\/j.sapharm.2024.02.016_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/medicina55070327","article-title":"Telepharmacy services: present Status and Future Perspectives: a review","volume":"55","author":"Baldoni","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.sapharm.2024.02.016_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1078155220987625","article-title":"Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City","volume":"27","author":"Yerram","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"17","key":"10.1016\/j.sapharm.2024.02.016_bib6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ajhp\/zxaa184","article-title":"Establishing clinical pharmacist telehealth services during the COVID-19 pandemic","volume":"77","author":"Segal","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2024.02.016_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1078155221991202","article-title":"Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic","volume":"27","author":"Marchese","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.sapharm.2024.02.016_bib8","series-title":"COVID-19 and Cancer","author":"Cancer Australia","year":"2023"},{"issue":"9","key":"10.1016\/j.sapharm.2024.02.016_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.sapharm.2020.12.002","article-title":"Video-based teleconsultations in pharmaceutical care \u2013 a systematic review","volume":"17","author":"Diedrich","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2024.02.016_bib10","article-title":"Telepharmacy during COVID-19: a scoping review","volume":"9","author":"Unni","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.sapharm.2024.02.016_bib11","unstructured":"Cristiane Soares Cardozo Wergles CVVG, Cec\u00edlia de Souza Fernandez et al. . Use of Telepharmacy to Support Patients Using Oral Antineoplastic Agents: A Pilot Study. available at: Research Square 2021(PREPRINT (Version 1)).."},{"key":"10.1016\/j.sapharm.2024.02.016_bib12","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.03048","article-title":"Oncology pharmacists' response to COVID-19 pandemic in Jordan: the king Hussein cancer center experience","volume":"11","author":"Al-Rabayah","year":"2021","journal-title":"J Glob Health"},{"key":"10.1016\/j.sapharm.2024.02.016_bib13","series-title":"Telepharmacy Models of Care for Adult Outpatients or Ambulatory Care Patients: A Systematic Review","year":"2023"},{"key":"10.1016\/j.sapharm.2024.02.016_bib14","article-title":"Global Health Evidence Evaluation Framework","author":"Shekelle","year":"2013"},{"issue":"4","key":"10.1016\/j.sapharm.2024.02.016_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2021.151173","article-title":"Multidisciplinary professional roles addressing needs in multiple myeloma: an Innovative \u2018virtual\u2019 pharmacist Surveillance clinic","volume":"37","author":"Ebied","year":"2021","journal-title":"Semin Oncol Nurs"},{"issue":"7716","key":"10.1016\/j.sapharm.2024.02.016_bib16","first-page":"332","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"issue":"12","key":"10.1016\/j.sapharm.2024.02.016_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (<em>Standards for QUality Improvement Reporting Excellence)<\/em>: revised publication guidelines from a detailed consensus process","volume":"25","author":"Greg","year":"2016","journal-title":"BMJ Quality & Safety"},{"issue":"5","key":"10.1016\/j.sapharm.2024.02.016_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1078155217709616","article-title":"The impact of pharmacist telephone calls after discharge on satisfaction of oncology patients: a randomized controlled study","volume":"24","author":"Salmany","year":"2018","journal-title":"J Oncol Pharm Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2024.02.016_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/tmj.2018.0077","article-title":"The effect of telephone-based follow-up on adherence, efficacy, and toxicity of oral capecitabine-based chemotherapy","volume":"25","author":"Eldeib","year":"2018","journal-title":"Telemedicine and e-Health"},{"issue":"10","key":"10.1016\/j.sapharm.2024.02.016_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/1357633X211048393","article-title":"Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency","volume":"27","author":"Ryan","year":"2021","journal-title":"J Telemed Telecare"},{"issue":"10","key":"10.1016\/j.sapharm.2024.02.016_bib21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/1357633X221122140","article-title":"An evaluation of telephone versus videoconference consults for pre-treatment medication history taking by cancer pharmacists","volume":"28","author":"Ryan","year":"2022","journal-title":"J Telemed Telecare"},{"issue":"12","key":"10.1016\/j.sapharm.2024.02.016_bib22","first-page":"1540","article-title":"Impact of pharmacists on identification of immune checkpoint inhibitor toxicities","volume":"4","author":"Linger","year":"2021","journal-title":"JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY"},{"key":"10.1016\/j.sapharm.2024.02.016_bib23","unstructured":"Tsumura S, Shimose S, Niizeki T, et al. Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib. J Gastroenterol Hepatol.n\/a(n\/a).."},{"issue":"11","key":"10.1016\/j.sapharm.2024.02.016_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ajhp\/zxac038","article-title":"Impact of a pharmacist-led telehealth oral chemotherapy clinic","volume":"79","author":"Mathur","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2024.02.016_bib25","unstructured":"State of Queensland (Queensland Health). Hospital and Health Services Funding and Purchasing Guidelines 2022-2023 Version 1.1. In: Health Q, ed. Brisbane2022.."},{"key":"10.1016\/j.sapharm.2024.02.016_bib26","series-title":"2021-22 Non-admitted Price Weights (N2122 and Q24) - Tier 2 Non-admitted Services Classification V7.0","author":"Queensland Government","year":"2022"},{"issue":"9","key":"10.1016\/j.sapharm.2024.02.016_bib27","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.sapharm.2022.02.003","article-title":"Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: a multi-method study","volume":"18","author":"Thomas","year":"2022","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.02.016_bib28","article-title":"Pharmacists \u2018dropping like flies\u2019 due to covid pressure","author":"Paola","year":"2022","journal-title":"Aust J Pharm"},{"issue":"6","key":"10.1016\/j.sapharm.2024.02.016_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jppr.1761","article-title":"The right time and place: the need for seven-day pharmacist service models","volume":"51","author":"Falconer","year":"2021","journal-title":"J Pharm Pract Res"},{"issue":"2","key":"10.1016\/j.sapharm.2024.02.016_bib30","article-title":"Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis","volume":"6","author":"Alemayehu","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2024.02.016_bib31","article-title":"Building on the momentum: Sustaining telehealth beyond COVID-19","author":"Thomas","year":"2020","journal-title":"J Telemed Telecare"},{"issue":"5","key":"10.1016\/j.sapharm.2024.02.016_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1357633X20916567","article-title":"Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)","volume":"26","author":"Smith","year":"2020","journal-title":"J Telemed Telecare"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T21:08:04Z","timestamp":1716325684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1551741124000810"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.02.016","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of synchronous telepharmacy service models for adult outpatients with cancer","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}